TEAS Plus New Application

VYNDAMAX

Wyeth LLC

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88369665
Filing Date: 04/03/2019

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\883\696\88369665\xml1\ FTK0002.JPG
*SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT VYNDAMAX
*COLOR MARK NO
*COLOR(S) CLAIMED
(If applicable)
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word "Vyndamax" with three curved lines, each tapering to a point, that form a flare design above and to the right of the letter "x".
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 944 x 250
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Wyeth LLC
*STREET 235 East 42nd Street
*CITY New York
*STATE
(Required for U.S. applicants)
New York
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
10017
PHONE 212-733-9778
FAX 212-573-2273
EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.pfizer.com
LEGAL ENTITY INFORMATION
*TYPE LIMITED LIABILITY COMPANY
* STATE/COUNTRY WHERE LEGALLY ORGANIZED Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Antifungal preparations; Pharmaceutical preparations for the treatment of a rare protein misfolding disease, namely, amyloidosis; Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Smoking cessation preparations; Human vaccine preparations; Pharmaceutical preparations for use in dermatology
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Janina Gorbach
ATTORNEY DOCKET NUMBER T426786
FIRM NAME Pfizer Inc.
STREET 235 East 42nd Street
CITY New York
STATE New York
COUNTRY United States
ZIP/POSTAL CODE 10017
PHONE 212-733-9778
FAX 212-573-2273
EMAIL ADDRESS deadlinesipnyo@pfizer.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Tiffany Trunko, Richard A. Friedman, Heather McDonald, Seana Smith
CORRESPONDENCE INFORMATION
*NAME Janina Gorbach
FIRM NAME Pfizer Inc.
*STREET 235 East 42nd Street
*CITY New York
*STATE
(Required for U.S. addresses)
New York
*COUNTRY United States
*ZIP/POSTAL CODE 10017
PHONE 212-733-9778
FAX 212-573-2273
*EMAIL ADDRESS deadlinesipnyo@pfizer.com; deborah.melita@pfizer.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
FEE PER CLASS 225
*TOTAL FEE PAID 225
SIGNATURE INFORMATION
* SIGNATURE /Janina Gorbach/
* SIGNATORY'S NAME Janina Gorbach
* SIGNATORY'S POSITION Corporate Counsel, New York bar member
SIGNATORY'S PHONE NUMBER 212-733-9778
* DATE SIGNED 04/03/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88369665
Filing Date: 04/03/2019

To the Commissioner for Trademarks:

MARK: VYNDAMAX (stylized and/or with design, see mark)

The mark in your application is VYNDAMAX.
The applicant is not claiming color as a feature of the mark. The mark consists of the word "Vyndamax" with three curved lines, each tapering to a point, that form a flare design above and to the right of the letter "x".
The applicant, Wyeth LLC, a limited liability company legally organized under the laws of Delaware, having an address of
      235 East 42nd Street
      New York, New York 10017
      United States
      212-733-9778(phone)
      212-573-2273(fax)
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
       International Class 005:  Antifungal preparations; Pharmaceutical preparations for the treatment of a rare protein misfolding disease, namely, amyloidosis; Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Smoking cessation preparations; Human vaccine preparations; Pharmaceutical preparations for use in dermatology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).



For informational purposes only, applicant's website address is: www.pfizer.com
The applicant's current Attorney Information:
      Janina Gorbach and Tiffany Trunko, Richard A. Friedman, Heather McDonald, Seana Smith of Pfizer Inc.      235 East 42nd Street
      New York, New York 10017
      United States
      212-733-9778(phone)
      212-573-2273(fax)
      deadlinesipnyo@pfizer.com (authorized)
The attorney docket/reference number is T426786.

The applicant's current Correspondence Information:
      Janina Gorbach
      Pfizer Inc.
      235 East 42nd Street
      New York, New York 10017
      212-733-9778(phone)
      212-573-2273(fax)
      deadlinesipnyo@pfizer.com;deborah.melita@pfizer.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Janina Gorbach/   Date: 04/03/2019
Signatory's Name: Janina Gorbach
Signatory's Position: Corporate Counsel, New York bar member
Signatory's Phone Number: 212-733-9778
Payment Sale Number: 88369665
Payment Accounting Date: 04/04/2019

Serial Number: 88369665
Internet Transmission Date: Wed Apr 03 15:14:43 EDT 2019
TEAS Stamp: USPTO/FTK-XXX.XXX.XX.XX-2019040315144363
4421-88369665-620b82311792b392d96c09d1e4
4305cb308e0bba317f06c646731d4bfbc822b-DA
-1463-20190403145604382365

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed